Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,310 | -27,220 | -19,933 | -12,048 | -81,011 |
| Depreciation Amortization | 450 | 351 | 252 | 737 | 65,055 |
| Income taxes - deferred | N/A | N/A | N/A | 53 | -17,244 |
| Accounts receivable | -102 | 14 | -98 | -47 | 545 |
| Other Working Capital | 217 | -528 | 596 | 1,786 | 2,450 |
| Other Operating Activity | 9,076 | 7,090 | 4,607 | 1,489 | -9,055 |
| Operating Cash Flow | $-23,668 | $-20,292 | $-14,576 | $-8,028 | $-39,258 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 6,984 |
| PPE Investments | -1,100 | -1,068 | -1,068 | -1,045 | -3,186 |
| Other Investing Activity | -1,750 | -1,248 | -635 | 0 | 0 |
| Investing Cash Flow | $-2,849 | $-2,316 | $-1,703 | $-1,045 | $3,798 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 804 | 369 | 369 | 369 | 133 |
| Debt Repayment | -9,349 | -9,349 | -6,349 | -6,349 | N/A |
| Common Stock Issued | 11,560 | 11,651 | 1,051 | 1,096 | 36,471 |
| Other Financing Activity | 17,888 | 18,226 | 18,589 | 19,065 | 0 |
| Financing Cash Flow | $20,904 | $20,896 | $13,660 | $14,181 | $36,604 |
| Beginning Cash Position | 20,318 | 20,318 | 20,318 | 20,318 | 19,174 |
| End Cash Position | 14,705 | 18,607 | 17,700 | 25,426 | 20,318 |
| Net Cash Flow | $-5,613 | $-1,712 | $-2,619 | $5,108 | $1,144 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,668 | -20,292 | -14,576 | -8,028 | -39,258 |
| Capital Expenditure | -1,100 | -1,068 | -1,068 | N/A | -3,186 |
| Free Cash Flow | -24,767 | -21,360 | -15,644 | -8,028 | -42,444 |